Reconciling drug brain penetration and tumor retention in glioblastoma through a size-switching DNA tetrahedron
Efficient drug delivery to glioblastoma is hindered by the blood-brain barrier (BBB) and by rapid drug clearance from tumor tissue. Here we describe a tetrahedral framework nucleic acid (tFNA) designed to maintain a small size to facilitate BBB penetration and form large aggregates only within tumor cells so as to improve the retention of the carried drug. tFNA self-aggregation occurs in the presence of overexpressed apurinic/apyrimidinic endonuclease 1, which cleaves apurinic/apyrimidinic linkers on the tFNA to expose G-rich domains, and of potassium, which triggers G-quadruplex formation. We enhances the translocation of the tFNA through the BBB and its tumoral accumulation by functionalizing it with BBB-penetrating and tumor-targeting aptamers. In an orthotopic mouse model of glioblastoma, the self-aggregating tFNA prolongs the residence of doxorubicin in the tumor and improves tumor suppression and animal survival when compared to non-aggregating controls. Our findings highlight the therapeutic advantages offered by the rational design of tumor-activated framework nucleic acids that couple molecular recognition to local drug retention.
Authors
- Haoxiang Chen (ORCID: https://orcid.org/0009-0005-2708-6603)
- Jinyue Fan (ORCID: https://orcid.org/0009-0008-7625-6500)
- Yang Gao
- Yunfeng Lin
- Xin Fu
- Yun Wang
- Chao Zhang
- Bo Wang
- Siyi Yang
- Yuanbo Zhao
Institutions
- Sichuan University (CN)
- Tianjin Huanhu Hospital (CN)
- Zhujiang Hospital (CN)
- Second Affiliated Hospital of Chengdu University of Traditional Chinese (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12951-026-05202-7
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00